Aging Rodent Core

$93,382P30FY2010AGNIH

University Of Michigan At Ann Arbor, Ann Arbor MI

Investigators

Linked publications, trials & patents

Paper 38464282 Paper 34964695 Paper 31929512 Paper 31357177 Paper 31026186 Paper 30888335 Paper 30070632 Paper 30013137 Paper 29695642 Paper 28415825 Paper 28267623 Paper 27851965 Paper 27786542 Paper 27777379 Paper 27337555 Paper 27135879 Paper 26913956 Paper 26756417 Paper 26704906 Paper 26490864 Paper 26331606 Paper 26268661 Paper 26136617 Paper 26086452 Paper 25878032 Paper 25829232 Paper 25826530 Paper 25819761 Paper 25808276 Paper 25792747 Paper 25675472 Paper 25484079 Paper 25456069 Paper 25411494 Paper 25324219 Paper 25283966 Paper 25233904 Paper 25189398 Paper 25156122 Paper 25127258 Paper 25088600 Paper 25070662 Paper 25040165 Paper 25005000 Paper 24978054 Paper 24947615 Paper 24920338 Paper 24847072 Paper 24825887 Paper 24821805 Paper 24735888 Paper 24703693 Paper 24691093 Paper 24645678 Paper 24522391 Paper 24515530 Paper 24358267 Paper 24341993 Paper 24325345 Paper 24292624 Paper 24240321 Paper 24219321 Paper 24178412 Paper 24150605 Paper 24055102 Paper 23982157 Paper 23941873 Paper 23844146 Paper 23819996 Paper 23806337 Paper 23760463 Paper 23755179 Paper 23733789 Paper 23729587 Paper 23707637 Paper 23657975 Paper 23576011 Paper 23551834 Paper 23528973 Paper 23441200 Paper 23437105 Paper 23386971 Paper 23374884 Paper 23345452 Paper 23328955 Paper 23264487 Paper 23248642 Paper 23246341 Paper 23227150 Paper 23217706 Paper 23155082 Paper 23115120 Paper 23106705 Paper 23071591 Paper 23067400 Paper 23063786 Paper 23044027 Paper 23034086 Paper 23028355 Paper 22981852

Abstract

Aging Rodent Core: Evan Keller, Director The central purpose of the Aging Rodent Core (ARC) is to promote the use of mutant and transgenic rodents for investigations of the cellular and molecular biology of aging and the relationship of the aging process to late life disease. The ARC will accomplish its goals through three inter-related initiatives. (1) ARC will pay for per diem costs for investigators who wish to produce aged mice, typically of mutant or transgenic or knockout stocks, that are not otherwise available at older ages. (2) ARC will work with the UM Transgenic Animal Model Facility (TAMF), directed by Sally Camper and Thom Saunders, to assist Shock Center investigators to pay for TAMF services needed to prepare new transgenic or KO mice (and rats) for work in biogerontology. (3) ARC will promote the incorporation of histopathology in such projects by subsidizing the costs of slide preparation for selected projects (roughly 2/year) involving the production of aged mice by NSC researchers. In all these efforts, the ARC Director will provide advice on protocol design and selection of appropriate animal models to UM faculty members who wish to use aged rodents for their studies.

View original record on NIH RePORTER →